COR — Cencora Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Cencora, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3,400	1,545	1,667	1,733	1,519
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	475	-95	270	442	650
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	6,269	366	-140	875	299
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,207	2,665	2,702	3,911	3,485
Capital Expenditures	-370	-438	-496	-458	-487
Purchase of Fixed Assets
Other Investing Cash Flow Items	-10.2	-5,703	128	-2,144	-131
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-380	-6,142	-368	-2,602	-618
Financing Cash Flow Items	-33.5	-13.7	-48.2	-80.7	-75.8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-604	1,953	-1,753	-2,222	-2,331
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,224	-1,528	523	-841	545